In a special edition 'Outrage of the Day,' Cramer has not one, but two gripes on his mind: one personal and one business, which is the one he decides to start with, since "we're not about making friends on this show, we're about making money."... Read More
When drug companies choose bullish, optimistic-sounding acronyms for clinical trials they should, perhaps, choose more wisely lest they backfire when the tests don't turn out like they hope they will... Read More